Trial
NCT01284504
Effect of Celecoxib on Perioperative Inflammatory Response in Colon Cancer
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Stanford University
Collaborators
—
Condition
Colorectal Cancer
Intervention
Celecoxib
Why stopped
low accrual rate; the only participant withdrew after signing consent
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-03-16